| RS1817882619 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1817884791 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1817884837 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1817885411 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1817887343 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1817889027 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1817890492 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1817891356 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1817892723 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1817893036 |
EXT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple congenital exostosis, Exostoses |
| RS1817893887 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1817895168 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Exostoses |
| RS1817896308 |
VLDLR
|
Health Risk |
Likely pathogenic |
Cerebellar ataxia, intellectual disability |
| RS1817930102 |
VLDLR
|
Health Risk |
Pathogenic |
Cerebellar ataxia, intellectual disability |
| RS181793341 |
PRKRA
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonia 16, Dystonia 16 |
| RS181794923 |
NF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 2 |
| RS181795958 |
MAN1B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Rafiq syndrome, Inborn genetic diseases |
| RS181796768 |
PEX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Zellweger spectrum disorders, Zellweger spectrum disorders |
| RS1817974591 |
TRPS1
|
Health Risk |
Likely pathogenic |
Trichorhinophalangeal dysplasia type I, Trichorhinophalangeal dysplasia type I |
| RS181798411 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS1817986949 |
TRPS1
|
Health Risk |
Likely pathogenic |
Trichorhinophalangeal dysplasia type I, Trichorhinophalangeal dysplasia type I |
| RS1817988877 |
TRPS1
|
Health Risk |
Pathogenic |
Trichorhinophalangeal dysplasia type I, Trichorhinophalangeal syndrome |
| RS1817997640 |
TRPS1
|
Health Risk |
Pathogenic |
Trichorhinophalangeal dysplasia type I, Trichorhinophalangeal syndrome |
| RS1818034687 |
TYRP1
|
Health Risk |
Pathogenic |
— |
| RS181805996 |
OTOF
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 9, Auditory neuropathy spectrum disorder |
| RS1818061499 |
TYRP1
|
Health Risk |
Pathogenic |
— |
| RS1818068588 |
TYRP1
|
Health Risk |
Pathogenic |
— |
| RS1818090088 |
FREM1
|
Health Risk |
Pathogenic |
— |
| RS1818111911 |
TYRP1
|
Health Risk |
Likely pathogenic |
— |
| RS1818111993 |
TYRP1
|
Health Risk |
Pathogenic |
— |
| RS1818126072 |
VLDLR
|
Health Risk |
Pathogenic |
— |
| RS181812684 |
CPLANE1
|
Health Risk |
Conflicting classifications of pathogenicity |
CPLANE1-related disorder, CPLANE1-related disorder |
| RS1818182191 |
TYRP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Oculocutaneous albinism type 3, Oculocutaneous albinism type 3 |
| RS1818211696 |
SPAG1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 28, Primary ciliary dyskinesia 28 |
| RS1818229100 |
TYRP1
|
Health Risk |
Likely pathogenic |
— |
| RS1818230091 |
TYRP1
|
Health Risk |
Pathogenic |
— |
| RS181823708 |
CRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Cone-rod dystrophy 2 |
| RS181826033 |
SLC25A19
|
Health Risk |
Pathogenic |
Progressive demyelinating neuropathy with bilateral striatal necrosis, Progressive demyelinating neuropathy with bilateral striatal necrosis |
| RS181826071 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS181827303 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS181827583 |
FANCM
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Hereditary breast ovarian cancer syndrome |
| RS1818287644 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1818287916 |
TYRP1
|
Health Risk |
Pathogenic |
— |
| RS1818289122 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1818289261 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1818289368 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1818312039 |
GLDC
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1818316799 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1818317027 |
CSPP1
|
Health Risk |
Pathogenic |
Joubert syndrome 21, Joubert syndrome 21 |
| RS1818317328 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS181834806 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS1818358114 |
TRPS1
|
Health Risk |
Likely pathogenic |
Trichorhinophalangeal dysplasia type I, Trichorhinophalangeal dysplasia type I |
| RS1818377152 |
SACK1H
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta, hypocalcification type |
| RS181837747 |
POR
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, POR-related disorder |
| RS1818404451 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1818405533 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1818407147 |
GLDC
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1818417633 |
CSPP1
|
Health Risk |
Pathogenic |
Joubert syndrome 21, Joubert syndrome 21 |
| RS181844178 |
GPR179
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital stationary night blindness 1E, Congenital stationary night blindness 1E |
| RS181844791 |
COLGALT1
|
Health Risk |
Pathogenic |
Brain small vessel disease 3, Brain small vessel disease 3 |
| RS1818457032 |
SPAG1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 28, Primary ciliary dyskinesia 28 |
| RS1818463608 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS181848049 |
MYPN
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary familial dilated cardiomyopathy, Dilated cardiomyopathy 1KK |
| RS181849614 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Dilated cardiomyopathy 3B |
| RS181850748 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex 5C, with pyloric atresia |
| RS181852740 |
HMCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Age related macular degeneration 1, Age related macular degeneration 1 |
| RS181854060 |
PDGFRA
|
Health Risk |
Conflicting classifications of pathogenicity |
Isolated cleft palate, Gastrointestinal stromal tumor |
| RS181854355 |
CYP7B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 5A, Spastic paraplegia |
| RS181856591 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, Multiple endocrine neoplasia type 2B |
| RS181858552 |
TRPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Trichorhinophalangeal syndrome |
| RS181859461 |
FREM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Oculotrichoanal syndrome, FREM1-related disorder |
| RS181860632 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, Progressive external ophthalmoplegia with mitochondrial DNA deletions |
| RS1818624667 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS181863443 |
RLBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Newfoundland cone-rod dystrophy, Pigmentary retinal dystrophy |
| RS181865675 |
SLC12A3
|
Health Risk |
Pathogenic |
Familial hypokalemia-hypomagnesemia, Familial hypokalemia-hypomagnesemia |
| RS1818665697 |
IKBKB
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to IKK2 deficiency, Severe combined immunodeficiency due to IKK2 deficiency |
| RS1818691758 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1818692381 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1818693456 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1818695432 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1818703974 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy 1 |
| RS1818705322 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1818740811 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1818749427 |
SLC52A2
|
Health Risk |
Pathogenic |
Brown-Vialetto-van Laere syndrome 2, Brown-Vialetto-van Laere syndrome 2 |
| RS1818749779 |
SLC52A2
|
Health Risk |
Pathogenic |
Brown-Vialetto-van Laere syndrome 2, Brown-Vialetto-van Laere syndrome 2 |
| RS1818768251 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1818768394 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS181882616 |
TPI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Triosephosphate isomerase deficiency, Triosephosphate isomerase deficiency |
| RS1818826951 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1818830393 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS181884470 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS181889379 |
ALDH3A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Sjögren-Larsson syndrome, Sjögren-Larsson syndrome |
| RS181889432 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS181890907 |
LCA5
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 5, Leber congenital amaurosis |
| RS181892217 |
DTHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS181892828 |
BLM
|
Health Risk |
Pathogenic |
Bloom syndrome, Bloom syndrome |
| RS1818930617 |
FGFR1
|
Health Risk |
Likely pathogenic |
Hypogonadotropic hypogonadism 2 with or without anosmia, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS1818935081 |
FGFR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypogonadotropic hypogonadism 2 with or without anosmia, FGFR1-related disorder |
| RS181894008 |
WNT5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant Robinow syndrome 1, Autosomal dominant Robinow syndrome 1 |
| RS1818974494 |
ANK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spherocytosis type 1, ANK1-related disorder |